Pecan AI vs Aidoc
A detailed comparison to help you choose between Pecan AI and Aidoc.
🏆
Verdict: Aidoc wins
Aidoc scores 4.2/5, edging out Pecan AI at 3.8/5. Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions.
Pecan AI Predictive analytics for business users | Aidoc AI powered radiology image analysis platform | |
|---|---|---|
| Rating | 3.8 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $500/mo | From $10000/mo |
| Best For | Mid-market data analysts with SQL skills who need one or two revenue-critical predictions — churn, LTV, ROAS, demand — delivered into operational systems without hiring data scientists. | Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | team featuressso | api accessteam featuresgdpr compliant |
| Visit Pecan AI → | Visit Aidoc → |
Pecan AI
Pros
- + End-to-end loop works for its target user: Predictive Question to scheduled predictions in a CRM or warehouse, with automated feature engineering in between
- + Prediction batch and storage limits are published per tier (Starter: 2 batches/month, 500M rows; Team: 10 batches, 2Bn rows), so capacity planning is possible even though prices are not
- + The AI assistant explains the selected influencing attributes and helps write SQL — reviewers specifically credit it with removing black-box anxiety
- + Strong support signal: G2 Relationship Index 7th of 33 in predictive analytics, with reviewers describing weekly calls and hands-on first-model enablement
- + Well funded for its size ($100M+ raised through Series C) with named mid-market and enterprise customers (Johnson & Johnson, SciPlay)
Cons
- - No dollar prices published on any tier at time of writing — all three plans route to 'Talk to sales', making budget checks slow
- - G2 reviewers flag missing data-drift and anomaly detection — a deployed model can degrade without a warning mechanism
- - Metered prediction batches (each scheduled run counts) mean frequent refreshes exhaust the Starter plan's 2 runs within days
- - Automated model selection only: no manual algorithm comparison or hyperparameter control for practitioners who want it
- - First results lean on Pecan's enablement team; a reviewer says setup would have been quite challenging without that support
Aidoc
Pros
- + Widest FDA-cleared acute triage portfolio I have reviewed: 31 authorisations on the FDA's December 2025 list, plus the first multi-indication clearance covering 14 abdominal CT findings in one workflow
- + Multi-triage consolidation meaningfully reduces alert noise — one flagged study produces one stacked panel, not one pop-up per algorithm
- + Real-world deployment evidence: Mercy Health documented urgent case turnaround falling from 19.8h to 1.3h across 50+ hospitals, with 5,642 patients expedited from 50,749 flagged findings
- + Vendor-neutral aiOS layer lets a health system run third-party and Aidoc algorithms through one governance and notification stack (17 FDA-cleared algorithms deployed at Hartford HealthCare)
- + Care Coordination and Patient Management close the loop beyond triage: mobile alerts with image context, and report mining that routes incidental findings to facility-defined follow-up protocols
Cons
- - No public pricing, no trial, no free tier — third-party estimates of ~$50k/site/year baseline with $8k-$15k per extra module are unverifiable until you are deep in a sales process
- - Hospital-only: requires PACS/RIS/EHR integration work, so it is irrelevant to individual clinicians, small practices and low-volume facilities
- - 510(k) clearance for most modules does not itself require independent clinical performance data (per JAMA Network Open) — buyers should demand the study set, not just the clearance count
- - No public changelog for algorithm updates, which is a real gap for a system whose output feeds clinical decisions
- - Vendor performance figures (order-of-magnitude false-alert reduction, 1,600+ hospitals) are company claims I could not independently audit
Frequently Asked Questions
Which is better, Pecan AI or Aidoc?▼
Aidoc scores higher at 4.2/5 vs 3.8/5 for Pecan AI, making it the better-rated option in our comparison.
What is the difference between Pecan AI and Aidoc?▼
Pecan AI: Pecan builds predictive models from business data to forecast outcomes such as churn, purchase and default, and delivers the predictions into the CRM. Aidoc: Aidoc analyses medical imaging to flag urgent findings for radiologists and care teams, prioritising the cases that need attention first.
Is Pecan AI or Aidoc more affordable?▼
Pecan AI starts at €500/mo, Aidoc starts at €10000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.